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Abstract 
 
Rats were subjected to 90 min of focal ischemia by occluding the left middle cerebral and 
both common carotid arteries. The dynamic changes in formation of brain ischemic 
areas were analyzed by measuring the direct current (DC) potential and NADH 
fluorescence with ultraviolet irradiation. In the lidocaine group (n = 10), 30 min before 
ischemia, an intravenous bolus (1.5 mg/kg) of lidocaine was administered, followed by a 
continuous infusion (2 mg/kg/h) for 150 min. In the control group (n = 10), an equivalent 
amounts of saline was administered. Following the initiation of ischemia, an area of 
high-intensity NADH fluorescence rapidly developed in the middle cerebral artery 
territory in both groups and the DC potential in this area showed ischemic 
depolarization. An increase in NADH fluorescence closely correlated with the DC 
depolarization. The blood flow in the marginal zone of both groups showed a similar 
decrease. Five minutes after the onset of ischemia, the area of high-intensity NADH 
fluorescence was significantly smaller in the lidocaine group (67% of the control; P = 
0.01). This was likely due to suppression of ischemic depolarization by blockage of 
voltage dependent sodium channels with lidocaine. Although lidocaine administration 
did not attenuate the number of peri-infarct depolarizations during the ischemia, the 
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high-intensity area and infarct volume were significantly smaller in the lidocaine group 
both at the end of ischemia (78% of the control; P = 0.046) and 24 h later (P = 0.02). A 
logistic regression analysis demonstrated a relationship between the duration of 
ischemic depolarization and histologic damage and revealed that lidocaine 
administration did not attenuate neuronal damage when the duration of depolarization 
was identical. These findings indicate that the mechanism by which lidocaine decreases 
infarct volume is primarily through a reduction of the brain area undergoing NADH 
fluorescence increases which closely correlates with depolarization. 
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1 Introduction 
 
Cerebral infarction is a potential consequence of brain ischemia, which may be induced 
by neurologic or cardiac surgery. Lidocaine may protect neurons during brain ischemia; 
a number of studies have suggested that lidocaine has neuroprotective effects. In 2 
randomized, double-blinded, prospective clinical studies, continuous administration of 
lidocaine significantly ameliorated postoperative cognitive dysfunction in patients 
undergoing cardiac surgery for left heart valve procedures (Mitchell et al., 1999) or 
coronary artery bypass surgery with cardiopulmonary bypass (Wang et al., 2002). In 
animal models of ischemia, administration of lidocaine has been shown to ameliorate 
cognitive dysfunction (Popp et al., 2011) and reduce infarct volume (Shokunbi et al., 
1990; Lei et al., 2001, 2004). Sodium entry and loss of membrane potential comprise 
some of the first steps in the development of ischemic neuronal damage. The primary 
neuroprotective mechanism of lidocaine may be related to blockade of 
voltage-dependent sodium channels, which results in suppression of cellular energy 
requirements (Fried et al., 1995; Raley-Susman et al., 2001; Seyfried et al., 2005) and 
delayed ischemic depolarization (Ayad et al., 1994; Liu et al., 1997). The mechanism by 
which lidocaine decreases infarction after focal ischemia is not fully understood but may 
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be associated with suppression of the size of the area of ischemic depolarization, an 
attenuation of the peri-infarct depolarizations (PIDs), and/or a reduction of neurologic 
damage during the ischemic depolarization. 
Nicotinamide adenine dinucleotide (NAD+/NADH) is an electron carrier in the 
mitochondrial respiratory chain. Under conditions of ischemia, NADH accumulates in 
mitochondria due to the increase in anaerobic glycolysis and an inhibition of 
mitochondrial oxidative phosphorylation. NADH fluorescence has been used in the past 
to identify the redox state of mitochondria (Eng et al., 1989; Takeda et al., 2004) due to 
the unique behavior of NADH which, when excited with ultraviolet light (366 nm), the 
reduced form (NADH) fluoresces (460 nm emission), while the oxidized form (NAD+) 
does not. Because membrane depolarization is accompanied by an increase in energy 
demand that leads to accumulation of NADH in mitochondria, dynamic changes on the 
cortical surface can be visualized by NADH fluorescence (Strong et al., 1996; Higuchi et 
al., 2002; Sasaki et al., 2009). 
The purpose of this study is to elucidate the effect of lidocaine on dynamic 
changes in areas of ischemic depolarization, the propagation of PIDs, and the 
relationship between ischemic depolarization and neurologic damage. We used 
simultaneous NADH fluorescence images and two-point direct current (DC) potential 
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measurements to provide both temporal and spatial observations during 90 min of focal 
ischemia. 
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2 Experimental Procedures 
 
2.1 Animals 
All experiments were performed in accordance with the National Institutes of Health 
Guide for the Care and Use of Laboratory Animals and were approved by the Animal 
Research Control Committee of Okayama University Medical School. All efforts were 
made to minimize the number of animals used and their suffering. Twenty-two male 
Sprague Dawley rats (Charles River Laboratories Japan, Yokahama, Japan), weighing 
304 ± 23 g, were used as a model of transient focal ischemia in this study. The animals 
were deprived of food for 8 h prior to the experiments. 
 
2.2 Experimental groups 
Animals were randomly assigned to 2 groups: the lidocaine group (n = 10) and the 
control group (n = 10). An additional 2 rats were placed in a separate sham operation 
group. In the lidocaine group, a bolus dose of lidocaine (1.5 mg/kg, at a concentration of 
1 mg/mL in saline) was administered intravenously 30 min before the initiation of 
ischemia. The bolus was followed by a continuous infusion of lidocaine at 2 mg/kg/h, 
which was continued until 30 min after reperfusion. In the control group, an equivalent 
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amount of saline was administered as sham treatment. 
 
2.3 General procedures 
Anesthesia was induced with a mixture of 4% isoflurane in oxygen. After oral tracheal 
intubation, anesthesia was maintained by artificial ventilation (SN-480–7, Shinano 
Manufacturing, Tokyo, Japan) with 2% isoflurane in 40% oxygen balanced with nitrogen. 
A polyethylene catheter (PE50) was placed in the right femoral artery for continuous 
mean arterial blood pressure monitoring and blood sampling and another was placed in 
the right femoral vein for administration of saline or lidocaine. Arterial blood gases 
were measured (i-STAT 300F, Abbott Point of Care, Princeton, NJ, USA) before the 
ischemia and maintained within the normal range. After the animal was placed in a 
stereotaxic apparatus (Narishige, Tokyo, Japan), an incision was made on the scalp. The 
parietal-temporal bone was exposed and the temporal muscles were partially resected. 
Then, a large cranial window (12 × 9 mm) was made in the left parietal-temporal bone 
for the observation of NADH fluorescence. The dura was left in place. To monitor the 
cortical depolarization associated with the initiation of focal ischemia, 2 borosilicate 
glass DC electrodes (World Precision Instruments, Sarasota, FL, USA), tip diameter < 5 
μm, were placed through dural incisions in the cranial window and lowered to a depth of 
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750 μm below the cortical surface. The positions of the electrodes were 2 mm posterior 
to the bregma and 2 mm and 4 mm lateral to the sagittal line, respectively. To measure 
regional cerebral blood flow (CBF), a laser Doppler flow probe (OmegaFlo FLO-C1, 
Omegawave, Tokyo, Japan) was placed adjacent to the distal DC electrode. Rectal 
temperature was monitored and maintained at 37.0 ± 0.5°C using a heated water 
blanket. Target brain surface temperature was maintained at 37°C in accordance with 
rectal temperature. To control the brain surface temperature, a gentle flow of warm 
saline was perfused over the brain surface (Kaplan et al., 1991). Since a pilot study 
determined that the brain surface temperature was within 1.0 ± 0.5°C below the drip 
temperature, the drip temperature was measured and maintained at 38.0 ± 0.1°C (brain 
surface temperature, 37.0 ± 0.5°C). 
The surgical preparation for the initiation of focal cerebral ischemia was 
performed as described by Buchan and colleagues (Buchan et al., 1992). The common 
carotid arteries (CCAs) were exposed bilaterally and loose ligatures were placed around 
them. The left middle cerebral artery (MCA) was accessed by piercing the dura inside 
the cranial window 0–1 mm above the rhinal fissure. Ischemia was initiated by 
tightening ligatures around the bilateral CCAs and by occluding the left MCA via lifting 
the vessel to 0–1 mm above the rhinal fissure with an 80-μm stainless-steel hook 
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attached to a micromanipulator. Reperfusion was initiated after 90 min of focal 
ischemia. The adequacy of circulation after relief of middle cerebral and common carotid 
artery occlusion was assessed by direct visual observation with a surgical microscope 
and by observing the increase in flow with laser Doppler flowmeter. After reperfusion, 
the removed fragment of the parietal-temporal bone was replaced and all wounds were 
closed. The rats were extubated and returned to their cages with free access to food and 
water. Despite partial removal of the parietal-temporal bone, rats were still able to eat 
and drink. The rats were allowed to survive for 24 h after the onset of ischemia. An 
additional 2 rats underwent a sham operation in which the hook was placed in contact 
with a portion of the MCA and removed without lifting the artery. 
 
2.4 Technique for cortical NADH fluorescence imaging 
The technique used for cortical NADH fluorescence imaging has previously been 
described in detail (Hashimoto et al., 2000; Higuchi et al., 2002; Sasaki et al., 2009). 
Briefly, to excite NADH in the cortical tissues, the cortical surface was illuminated 
using a 200-W Xenon lamp (Hamamatsu Photonics, Hamamatsu, Japan) equipped with 
a 365-nm bandpass filter (Asahi Spectra, Tokyo, Japan). Images of NADH fluorescence 
were obtained using a charge-coupled device camera (ST-9XE, Santa Barbara 
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Instrument Group, Santa Barbara, CA, USA) with a 460-nm bandpass filter. Images 
(170 × 170 pixels, width × height) were captured every 15 s. Fluorescence intensity 
values for each pixel in each NADH fluorescence image were divided by those of the 
control image obtained before the initiation of focal ischemia and the percent change 
(80–120%) in NADH fluorescence was expressed in each pixel using a 256 gray-scale. 
 
2.5 Histologic evaluation 
Twenty-four hours after the onset of ischemia, all animals were anesthetized with 4% 
isoflurane. After inserting a cannula into the ascending aorta, each animal was 
perfused with heparinized physiologic saline (20 units/mL) and 6% paraformaldehyde in 
0.1 mol/mL phosphate buffer (pH 7.4). The brain of each animal was removed, 
embedded in paraffin, and sectioned (5 μm thick) at 1000 μm intervals. To identify the 
DC recording site, the location was recorded in a photograph in which arteries and veins 
can be identified for each rat at the time of electrode insertion. The DC recording site 
was identified after perfusion-fixation and marked using a 27-gauge needle with blue 
ink on the tip of the needle. The DC recording sites were also sectioned, as described 
above. All sections were stained with hematoxylin and eosin, examined, and 
photographed.  
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Images were analyzed for infarct areas by a researcher blinded to the 
experimental group. Infarct volumes were calculated by multiplying the infarct area by 
the slice thickness and integrating over all slices. In addition, at the sites of DC 
measurement, the number of injured pyramidal neurons in the fifth layer of the 
parietal-temporal cortex was counted by an observer who was blinded to the study. The 
percent neuronal damage was calculated as the number of damaged neurons divided by 
the total number of neurons, in the visual field × 100. Pyramidal neurons showing 
aggregated chromatin in the nucleus, shrinkage, or eosinophilic staining in the 
cytoplasm were considered injured. 
 
2.6 Statistical analysis 
Experimental data are expressed as mean ± standard deviation (SD). Linear regression 
models were used to evaluate the correlation between percent changes in NADH 
fluorescence and the magnitude of negative DC deflection. A probit regression curve was 
used to evaluate the relationship between neuronal injury and total duration of 
ischemic depolarization at the site of the DC electrode. A linear regression model was 
not used to evaluate the correlation since it is likely that the probability of neuronal 
injury converges to 100% with a very long duration of ischemic depolarization. Instead, 
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a probit curve, which expresses the probability of occurrence and is generally used to 
identify the LD50 in toxicology, was used. The linear model and the probit curve were 
drawn using personal-computer software (Origin 8, OriginLab Corporation, 
Northampton, MA, USA). Parameters obtained from the NADH fluorescence images 
and the measurements of CBF were analyzed by repeated measures analysis of 
variance (ANOVA). A Scheffé’s F-test was used as a post hoc test if the ANOVA was 
significant. The physiologic parameters and infarct volumes were compared between 
the lidocaine and control groups using Student’s t-test. A P-value < 0.05 was considered 
significant for all statistical tests. 
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3 Results  
Baseline values of physiologic parameters were measured before the induction of focal 
ischemia and are shown in Table 1. The values of all parameters were maintained 
within normal limits throughout the experimental period. There were no significant 
differences in mean arterial blood pressure, arterial pH, arterial oxygen tension, 
arterial carbon dioxide tension, hemoglobin, or blood glucose concentration between the 
control and lidocaine groups. 
 
3.1 Measurements of NADH fluorescence and DC potential 
The DC potential was successfully measured at 20 sites in the control group and at 20 
sites in the lidocaine group. The DC recording was divided into 2 types according to the 
pattern of negative DC deflection: (1) peri-infarct depolarization (PID), in which the DC 
potential showed recurrent depolarization during the 90-min ischemic period and (2) 
persistent depolarization, in which persistent depolarization of the DC was observed 
during the 90-min ischemic period. Patterns that initially showed recurrent 
depolarization, but were eventually replaced by persistent depolarization were 
categorized as persistent depolarization. The number of DC electrodes that recorded 
either PIDs or persistent depolarizations is listed in Table 2. Representative traces 
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illustrating the DC recordings and the intensity of NADH fluorescence in areas adjacent 
to the distal DC electrode (3 × 3 pixels: 255 × 255 μm2) are shown in Figure 1. The 
intensity of NADH fluorescence changed simultaneously with the negative DC 
deflection and the waveforms of NADH fluorescence were analogous to those of the DC 
potential. No DC deflection was observed without an accompanying increase in NADH 
fluorescence and no increase in NADH fluorescence was observed without an 
accompanying DC deflection. As shown in Figure 2, the peak fluorescence value 
(percent change from the control) was closely related to the magnitude of negative DC 
deflection (control: r2 = 0.89, P < 0.001; lidocaine: r2 = 0.89, P < 0.001). Due to the 
similarities in the linear regression relationships between the control and lidocaine 
groups and the fact that 15 mV magnitude of negative DC deflection corresponded to 
120% of the pre-ischemia level of NADH fluorescence, in this study, 80–120% NADH 
fluorescence was expressed in 256 gray-scales and high-intensity NADH fluorescence 
was defined as a signal with NADH fluorescence > 120% of the pre-ischemia signal 
(expressed using a white pixel). 
 
3.2 Dynamic changes in NADH fluorescence 
After the initiation of ischemia, the development of high-intensity fluorescence was 
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observed using a series of NADH fluorescence images. Figure 3 and Figure 4 illustrate 
the serial changes in NADH fluorescence under ischemic conditions with or without 
lidocaine. A high-intensity region rapidly developed from the proximal to the distal 
region of the MCA territory. Five minutes after the initiation of ischemia, the size of 
these initial high-intensity areas were significantly smaller in the lidocaine group (67% 
of control) compared to the control group (control: 8083 ± 1917 pixels, 58.4 ± 13.9 mm2 vs. 
lidocaine: 5382 ± 2273 pixels, 38.9 ± 16.4 mm2; P = 0.01). As shown in Figure 4, the size 
of the area with high-intensity fluorescence (>120% pre-ischemia) increased gradually, 
and then plateaued. Throughout the observation period, the area of high-intensity 
fluorescence was smaller in the lidocaine group compared to the control group. The size 
difference between the high-intensity areas in the 2 groups became smaller with time. 
However, before reperfusion, the area of high-intensity NADH fluorescence was 
significantly smaller in the lidocaine group, at 78% of the control group (control: 7613 ± 
2056 pixels, 55.0 ± 14.9 mm2 vs. lidocaine: 5904 ± 1456 pixels, 42.7 ± 10.5 mm2; P = 
0.046). 
Several minutes after the formation of the high-intensity fluorescence area, 
waves of high-intensity fluorescence (which may correlate with PIDs), with a width of 
1–3 mm, were observed at the edges of the high-intensity areas and propagated along 
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the area. The typical pattern of PID propagation, together with persistent 
depolarization, is shown in Figure 5. During ischemia, 26 waves were observed in the 
control group and 23 waves were observed in the lidocaine group. The majority of these 
waves, in both groups, disappeared without sequelae. However, 7 of 26 waves (26.9%) in 
the control group and 5 of 23 waves (21.7%) in the lidocaine group did not disappear and 
eventually enlarged the area of high-intensity NADH fluorescence. The frequencies of 
these PID-like waves per rat (control: 2.6 ± 1.3 times/rat vs. lidocaine: 2.3 ± 1.4 
times/rat; P = 0.60) and the appearance of the first (control: 10.8 ± 2.8 min vs. lidocaine: 
10.8 ± 4.1 min; P = 0.96) and second (control: 28.2 ± 17.7 min vs. lidocaine: 33.1 ± 11.9 
min; P = 0.55) PID-like waves were not significantly different between the 2 groups. 
The present and previous studies (Higuchi et al., 2002; Sasaki et al., 2009) 
have shown that the majority of the high-intensity NADH fluorescence area forms in 
approximately 5 min, and that PID-like waves then propagate around the 
high-intensity area and occasionally enlarge it. Therefore, in this study, we defined the 
ischemic core as the area of high-intensity NADH fluorescence that forms in 5 min and 
then gradually enlarges with PID-like waves, and the penumbra (potentially 
salvageable area) as the distal area external to the high-intensity NADH fluorescence 
area into which the PID-like waves propagate. 
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3.3 Measurements of the cerebral blood flow 
The CBF in the marginal zone was measured using a laser Doppler flowmeter placed 
adjacent to the distal DC electrode. As shown in Table 2, at this location, 50% of the 
cases in the control group showed PIDs (site at penumbra) and 50% showed persistent 
depolarization (site at ischemic core). CBF was successfully measured at 10 sites in the 
control group and at 9 sites in the lidocaine group. As shown in Figure 6, immediate 
reduction of CBF was observed after the onset of ischemia. CBF remained 
approximately stable for the duration of the 90-min ischemic period. There were no 
significant differences between the 2 groups during the experiment (P = 0.97). CBF was 
not affected by the propagation of waves of NADH fluorescence. 
 
3.4 Histologic outcome at the DC recording sites 
Figure 7 illustrates the close relationship between the total depolarization time during 
the 90-min ischemic period and the percent of damaged pyramidal neurons in the fifth 
layer of the parietal-temporal cortex at the DC recording site, as determined by a probit 
logistic regression curve (control: r2 = 0.97, P < 0.001; lidocaine: r2 = 0.97, P < 0.001). The 
P50, the total duration of depolarization that induced ischemic cell changes in 50% of the 
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pyramidal neurons, was estimated (along with corresponding 95% confidence intervals) 
to be 19.8 min (15.9–25.0 min) in the control group and 20.4 min (17.4–23.4 min) in the 
lidocaine group. The 95% confidence intervals in both groups overlapped from 
end-to-end, indicating that there was no significant difference between the 2 groups in 
the duration of depolarization necessary to cause identical neuronal damage. 
 
3.5 Infarct size 
As shown in Figure 8, the infarct volume 24 h after the onset of ischemia in the 
lidocaine group was significantly smaller than that in the control group (control: 122.9 ± 
31.0 mm3 vs. lidocaine: 90.4 ± 26.9 mm3, P = 0.02) 
 
In the 2 rats that underwent sham operations, no changes were observed in 
NADH fluorescence, DC potential, and CBF during the observation period. Almost no 
neuronal damage was detected by microscopic observation 24 h after the sham 
operation. 
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4 Discussion 
Lidocaine, which is well known as a sodium channel-blockade, has been widely used as 
a local anesthetic and antiarrhythmic agent. Numerous laboratory studies have 
suggested that lidocaine can reduce ischemic neuronal injury. As shown in Table 3, 
administration of lidocaine ameliorates the electrophysiological activities and reduces 
infarct volume during focal ischemia. Lei et al. (2001) reported that continuous 
administration of lidocaine at a clinical dose reduced cerebral infarct size at 48 h and 7 
days after MCA occlusion, improved neurologic outcome, and inhibited post-ischemic 
weight loss in rats. As shown in Table 4, administration of lidocaine has been reported 
to delay the onset of depolarization (Ayad et al., 1994; Liu et al., 1997; Raley-Susman et 
al., 2001; Seyfried et al., 2005), reduce the amplitude of negative DC deflection (Ayad et 
al., 1994; Raley-Susman et al., 2001), and facilitate the recovery of membrane potential 
from depolarization (Weber and Taylor, 1994; Niiyama et al., 2005). Primary 
neuroprotective mechanism of lidocaine may be related to blockade of 
voltage-dependent sodium channels, which results in suppression of cellular energy 
requirements and suppression of ischemic depolarization. However, the mechanism by 
which lidocaine reduces infarction after transient focal ischemia has not been 
elucidated. The results of this study suggest that the most likely mechanism underlying 
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infarct reduction is a reduction of the area of persistent depolarization. 
In this study, a 1.5 mg/kg bolus dose of lidocaine was administered 30 min prior 
to induction of ischemia and lidocaine administration continued at a rate of 2 mg/kg/h. 
Lei et al. (2001), administered the same dose of lidocaine and reported plasma lidocaine 
concentrations of 1.2 ± 0.4 μg/mL, 75 min after beginning lidocaine administration. 
Although plasma concentrations of lidocaine were not measured in the current study, 
the lidocaine dose and animals used in the current study were identical to those used in 
the previous report (Lei et al., 2001). Therefore, the plasma concentration of lidocaine 
was assumed to be similar to these previously reported concentrations. Clinically, the 
effective plasma lidocaine concentration has been reported as 1.5 μg/mL, when used for 
antiarrhythmic purposes (Jewitt et al., 1968; Grossman et al., 1969) and it is known 
that serum concentrations > 5 μg/mL can be toxic (Roden, 2006). Therefore, the dose 
used in this study represents an antiarrhythmic dose or smaller and is a dose that 
would be feasible for clinical administration. 
In both the control and lidocaine groups, the intensity of NADH fluorescence 
was closely related to the magnitude of DC deflection, as illustrated by the overlap in 
95% confidence intervals for the linear regressions (Figure 2). During depolarization, 
since the increase in cellular energy demand necessary for restoration of ion 
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homeostasis is closely associated with the magnitude of DC deflection (Lipton, 1999), 
large DC deflections may reflect increased glycolysis and result in the increased 
intensity of NADH fluorescence. Furthermore, Strong et al. (1996), Higuchi et al. (2002), 
and Sasaki et al. (2009) observed a simultaneous increase in NADH fluorescence and 
negative DC deflection during ischemic depolarization and propagation of PIDs in 
animal models. Similarly, Hashimoto et al. (2000) observed a simultaneous increase in 
NADH fluorescence and negative DC deflection during the propagation of spreading 
depression in gerbils. 
Five minutes after the initiation of ischemia, the size of the area that developed 
high-intensity NADH fluorescence in the lidocaine group was 67% of the size of the area 
in the untreated ischemic (control) group. This result suggests that administration of 
lidocaine improved the balance in mitochondrial energy supply and demand at the 
periphery of ischemic area. In this study, no significant difference was demonstrated 
between the 2 groups with respect to the CBF measured in the marginal zone. Using the 
same lidocaine dose, Lei et al. (2002, 2004) found no significant difference in CBF at 
either the core or the penumbral areas with administration of lidocaine. Therefore, in 
the current study, it is assumed that lidocaine decreased energy consumption by 
suppressing loss of membrane potential with the blockade of voltage-dependent sodium 
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channels. In support of this notion, Raley-Susman et al. (2001) and Niiyama et al. 
(2005) administered a 10-μM dose of lidocaine in rat brain slices and found that the loss 
of membrane potential was suppressed and that the ATP level was preserved at 5 min 
and 6 min after the induction of ischemia. 
PIDs are thought to contribute to infarct expansion because of a positive 
relationship between infarct volume and the number of PIDs (Iijima et al., 1992; Mies et 
al., 1993). NADH fluorescence waves, which are highly correlated with the PIDs, were 
similar in the control and lidocaine groups with respect to the onset time and the 
number of waves generated. In the penumbra, PIDs are thought to be generated by 
glutamate and potassium released from the ischemic core (Mies et al., 1994; Dirnagl et 
al., 1999). Previous studies have reported that administration of lidocaine did not 
suppress glutamate release at doses < 5 mg/kg (Terada et al., 1999). Since the lidocaine 
was infused at the rate of 2 mg/kg/h (total dose: 5 mg/kg in 150 min) in this study, 
glutamate release was not likely to be suppressed. Therefore, the onset time and 
number of PIDs may not have been affected in the present study. 
Since ischemic depolarization is an early step in the ischemic cascade, it is 
considered one of the most important factors affecting the degree of neuronal damage 
(Li et al., 2000). From the perspective of ischemic depolarization, neuroprotective 
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mechanisms can be summarized in 2 categories: (1) to decrease neuronal damage by 
reducing the area and duration of ischemic depolarization and (2) to decrease neuronal 
damage by inhibiting the ischemic cascades, triggered by calcium influx following loss of 
membrane potential during ischemia. In this study, areas of high-intensity NADH 
fluorescence were decreased with administration of lidocaine. Since the intensity of 
NADH fluorescence and negative DC deflection were highly correlated, the 
neuroprotective effect of lidocaine is likely exerted by the first category, reducing the 
area of NADH fluorescence which corresponds to the area of persistent depolarization. 
The relationship between the duration of ischemic depolarization and neuronal 
damage is shown in Figure 7. Both groups demonstrated a high correlation between 
these variables (lidocaine: r2 = 0.97, P < 0.001; control: r2 = 0.97, P < 0.001) and their 
curves overlap. Furthermore, the total time at which 50% of the neurons show damage 
(P50) was 20.4 min in the lidocaine group, which is similar to the 19.8-min P50 in the 
control group. These findings indicate that the continuous administration of lidocaine 
did not affect neuronal damage once persistent depolarization had occurred, likely due 
to a lack of inhibition of the ischemic cascades. 
In conclusion, a continuous infusion of a clinically used antiarrhythmic dose of 
lidocaine decreased the volume of the cerebral infarct by decreasing the area of the 
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NADH fluorescence, this correlates with the depolarized ischemic core in which the 
mitochondrial oxygen demand is increased. Since administration of lidocaine did not 
attenuate the number of NADH fluorescent PID-like waves during ischemia and did not 
attenuate neuronal damage when the duration of depolarization was the same, the most 
likely mechanism underlying infarct reduction is a reduction of the area of persistent 
depolarization. 
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Figures 
Figure 1 
 
Representative traces showing cerebral blood flow (CBF), NADH fluorescence in areas 
adjacent to the distal direct current (DC) electrode (3 × 3 pixels: 255 × 255 μm2) and the 
DC potential of the peri-infarct depolarizations (PIDs) and the persistent depolarization. 
The waveform representing NADH fluorescence was analogous to the changes in DC 
potential. 
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Figure 2 
 
Relationships between the percent change in NADH fluorescence and the magnitude of 
negative direct current (DC) deflection were evaluated using linear regression models. 
The black line and circles represent the control group and the gray line and triangles 
represent the lidocaine group. 95% confidence intervals are shown with dotted lines 
(Control group: r2 = 0.89, P < 0.001; Lidocaine group: r2 = 0.89, P < 0.001). 
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Figure 3 
 
(A and B) Sequences of NADH fluorescence images. The dashed lines in (A) and (B) 
represent the cranial window. For visualization of changes in NADH fluorescence, data 
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for each pixel in each NADH fluorescence image was divided by that of the control 
image obtained before the initiation of focal ischemia. The percent change in NADH 
fluorescence (80–120%) was expressed in each pixel with 256 gray-scales. These 
sequences represent the development of areas of high-intensity NADH fluorescence 
following the initiation of ischemia with or without lidocaine. (A) Formation of the 
ischemic core (before ischemia to 10 min following initiation of ischemia). Images 
captured every 1 min are shown. The first image (left top) was taken prior to initiation 
of ischemia. The wave of high-intensity NADH fluorescence (shown in white) spreads 
from the area of the middle cerebral artery occlusion. The high-intensity area forms 
rapidly after the initiation of ischemia, originating from the parietal cortex and 
propagating along the ischemic core in the anterior and posterior directions. (B) Images 
during ischemia (from 10 min following initiation of ischemia to 90 min, the end of 
ischemia). Areas of high-intensity NADH fluorescence were suppressed during ischemia 
in the lidocaine group. (C) A schematic drawing of the cranial window. The shaded area 
represents the large cranial window made on the left parietal-temporal bone. The left 
middle cerebral artery was observed and occluded inside the cranial window. DC1 and 
DC2 represent the locations of direct current recording sites.  
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Figure 4 
 
Development of areas of high-intensity NADH fluorescence and the frequency 
distribution of peri-infarct depolarizations (PIDs). The line graph corresponds to the 
number of pixels with >120% of the pre-ischemic levels of NADH fluorescence (i.e., the 
high-intensity area). The gray line represents the lidocaine group and the black line 
represents the control group. Throughout the observation period, the area of 
high-intensity NADH fluorescence was smaller in the lidocaine group compared to the 
control group (*P < 0.05). The bar graph shows the frequency distribution of PIDs in the 
control group (black) and the lidocaine group (white). 
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Figure 5 
 
A typical pattern of the propagation of a peri-infarct depolarization (PID) and persistent 
depolarization. The percent change in NADH fluorescence (80–120%) was expressed in 
each pixel using 256 gray-scales. Images (A)–(F) correspond to the times Illustrated 
with gray lines in the graph (lower panel). Circles (red) in the cranial window represent 
the locations of the direct current (DC) electrodes and correspond to the DC1 and DC2 
recording sites. The graph shows NADH fluorescence in areas adjacent to the distal DC 
electrode (3 × 3 pixels: 255 × 255 μm2) and the direct current (DC) potential at each 
recording site. Waves of high-intensity NADH fluorescence with persistent 
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depolarization (ischemic core), detected by subtracting the neighboring image, are 
superimposed on the images in green. DC2 is involved in the area that shows persistent 
depolarization (C)–(F). A PID-like wave, detected by subtracting the neighboring image, 
is superimposed on the images in blue. At DC1, a PID-like wave propagates around the 
ischemic core and disappeared without enlarging the area of high-intensity NADH 
fluorescence (D)–(F). 
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Figure 6 
 
Changes in cerebral blood flow (CBF) measured by a laser Doppler flowmeter in the 
marginal zone. The laser Doppler probe was placed adjacent to the distal direct current 
(DC) electrode. The gray line shows the lidocaine group and the black line represents 
the control group. There was no significant difference between the 2 groups (P = 0.97). 
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Figure 7 
 
Relationship between the total duration of ischemic depolarization and the percent 
damaged pyramidal neurons at the direct current (DC) recording sites in the fifth layer 
of the parietal-temporal cortex. Black lines with circles represent the control group and 
gray lines with triangles represent the lidocaine group (Control: r2 = 0.97, P < 0.001; 
Lidocaine: r2 = 0.97, P < 0.001), while 95% confidence intervals (CI) are shown with 
corresponding dotted lines. Logistic regression curves showed close relationships 
between the duration of ischemic depolarization and the percent damaged neurons. The 
total duration of depolarization causing ischemic cell change in 50% of the pyramidal 
neurons (P50) in the control and lidocaine groups was estimated to be 19.8 min (95% CI: 
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15.9–25.0 min) and 20.4 min (95% CI: 17.4–23.4 min), respectively. 
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Figure 8 
 
Infarct size 24 h after reperfusion in the control and lidocaine groups. Brain sections (5 
μm thick) were prepared at 1000-μm intervals and stained with hematoxylin and eosin. 
Infarct volumes were calculated by multiplying the infarct area by the slice thickness 
and integrating over all slices. Infarct size in the lidocaine group was significantly 
smaller (*P = 0.02) compared to the control group. 
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Tables 
Table 1. Physiological parameters before the ischemia 
    Control (n = 10)       Lidocaine (n = 10) 
Body weight (g)   298 ± 19.9       297 ± 22.6 
MABP (mmHg)   84.2 ± 7.24           87.0 ± 8.3 
Arterial pH   7.44 ± 0.04          7.43 ± 0.03 
PaO2 (mmHg)   151.4 ± 32.1          138.8 ± 29.4 
PaCO2 (mmHg)   39.0 ± 2.67           40.1 ± 2.45 
Hb (g/dL)   13.9 ± 1.21  14.1 ± 1.04 
Glucose (mg/dL)   143.3 ± 31.7          162.7 ± 33.6 
Values are expressed as means ± S.D. MABP, mean arterial blood pressure; PaO2, 
partial pressure of oxygen (arterial); PaCO2, partial pressure of carbon dioxide 
(arterial); Hb, hemoglobin 
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Table 2. Number of DC deflection types in each recording site. 
Persistent  Peri-infarct  Not depolarized 
depolarization  depolarization 
Distal electrode (DC1) 
Control (n = 10)   5    5    0 
Lidocaine (n = 10)  4    5    1 
Proximal electrode (DC2) 
Control (n = 10)   10    0    0 
Lidocaine (n = 10)  7    2    1 
Total 
Control (n = 20)   15    5    0 
Lidocaine (n = 20)  11    7    2 
The locations of the direct current (DC) recording sites DC1 and DC2 are shown in 
Figure 3 (C). 
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Table 3. Effect of lidocaine during focal ischemia 
Year published Authors  Animal Ischemia model (duration)  Intravenously administered dose Evaluation method   Outcome 
1984  Evans et al. Cat Air embolism  5 mg/kg    SER    Improved 
1986  Shokunbi et al. Cat MCA occlusion (4h or 6h) 50 mg/kg + 50 mg/kg/h  Histology    Unchanged 
1988  Gelb et al.  Cat MCA occlusion (6h)  5 mg/kg    SER, histology   Partially improved 
1989  Evans et al. Cat Air embolism  1.5 mg/kg + 3 mg/kg + 1 mg/kg (repeated) SER    Improved 
1990  Shokunbi et al. Cat MCA occlusion (3h)  5 mg/kg + 3 mg/kg + 2 mg/kg/h  SER, CBF, histology   Improved 
1992  Dutka et al. Dog Air embolism  1.5 mg/kg + 1 mg/kg (repeated)  SER, CBF    Improved 
2001  Lei et al.  Rat MCA occlusion (90min) 1.5 mg/kg + 2 mg/kg/h   Histology, neurologic score  Improved 
2002  Lei et al.  Rat MCA occlusion (90min) 1.5 mg/kg + 2 mg/kg/h   CBF, histology, neurologic score  Improved 
2004  Lei et al.  Rat MCA occlusion (90min) 1.5 mg/kg + 2 mg/kg/h   CBF, histology   Improved 
SER, somatosensory evoked response; MCA, middle cerebral artery; CBF, cerebral blood flow 
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Table 4. Neuroprotective mechanisms of lidocaine during brain ischemia 
Year published  Authors  Animal (model)  Improved evaluation points 
1990  Rasool et al.  Rabbit (global ischemia)  Facilitated the recovery of somatosensory evoked potentials  
1994  Ayad et al.  Rabbit (global ischemia)  Delayed the onset ischemic depolarization; reduced the amplitude of negative DC deflection 
1994  Fujitani et al.  Gerbil (global ischemia)  Suppressed concentration of extracellular excitatory amino acids (aspartate, glutamate, glycine, taurine) 
1994  Weber and Taylor Rat (hippocampal slices)  Facilitated the recovery of membrane potential from ischemic depolarization 
1995   Diaz et al.  Rat (striatal slices)  Suppressed concentration of extracellular D-aspartic acid 
1995  Fried et al.  Rat (hippocampal slices)  Facilitated the recovery of evoked population spike; preserved ATP content; reduced Na+ influx during ischemia 
1995  Taylor et al.  Rat (hippocampal slices)  Reduced the percentage of depolarized hippocampal slices; suppressed concentration of extracellular glutamate 
1997  Liu et al.  Gerbil (global ischemia)  Delayed the onset of ischemic depolarization; suppressed intracellular Ca2+ increase 
1999  Terada et al.  Rat (global ischemia)  Suppressed concentration of extracellular glutamate 
1999  Zhang and Lipton Rat (hippocampal slices)  Reduced Na+ influx during ischemia; suppressed intracellular Ca2+ increase 
2001  Lopachin et al.  Rat (hippocampal slices)  Reduced Na+ influx during ischemia 
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2001  Raley-Susman et al. Rat (hippocampal slices)  Delayed the onset of ischemic depolarization; reduced the amplitude of negative DC deflection; preserved ATP content; reduced Na+ influx during ischemia 
2004  Yamada et al.  Rat (hippocampal slices)  Delayed the onset of ischemic depolarization 
2005  Niiyama et al.  Rat (hippocampal slices)  Facilitated the recovery of membrane potential from ischemic depolarization; preserved ATP content 
2005  Seyfried et al.  Mouse (global ischemia)  Delayed the onset of ischemic depolarization; preserved ATP content 
ATP, adenosine triphosphate; DC, direct current 
 
